Merck Says Jury Rules in Its Favor in Fosamax Trial
This article is for subscribers only.
Merck & Co., the second-biggest U.S. drugmaker, said a jury found in its favor in a trial over claims its Fosamax osteoporosis treatment caused a woman’s femur to fracture spontaneously while she was gardening.
The verdict was handed down today in federal court in Trenton, New Jersey, Merck said in a statement, and it couldn’t immediately be confirmed in court records. The case is the first of about 3,300 femur-fracture lawsuits against the company to be decided by a jury.